001     298907
005     20250407104341.0
024 7 _ |a 10.1016/j.stem.2025.01.002
|2 doi
024 7 _ |a pmid:39938519
|2 pmid
024 7 _ |a 1934-5909
|2 ISSN
024 7 _ |a 1875-9777
|2 ISSN
024 7 _ |a altmetric:174079047
|2 altmetric
037 _ _ |a DKFZ-2025-00346
041 _ _ |a English
082 _ _ |a 570
100 1 _ |a Peng, Tianping
|b 0
245 _ _ |a Individualized patient tumor organoids faithfully preserve human brain tumor ecosystems and predict patient response to therapy.
260 _ _ |a Amsterdam [u.a.]
|c 2025
|b Elsevier
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1744015377_31488
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a DKFZ-ZMBH Alliance / #EA:A240# / HI-TRON / 2025 Apr 3;32(4):652-669.e11
520 _ _ |a Tumor organoids are important tools for cancer research, but current models have drawbacks that limit their applications for predicting response to therapy. Here, we developed a fast, efficient, and complex culture system (IPTO, individualized patient tumor organoid) that accurately recapitulates the cellular and molecular pathology of human brain tumors. Patient-derived tumor explants were cultured in induced pluripotent stem cell (iPSC)-derived cerebral organoids, thus enabling culture of a wide range of human tumors in the central nervous system (CNS), including adult, pediatric, and metastatic brain cancers. Histopathological, genomic, epigenomic, and single-cell RNA sequencing (scRNA-seq) analyses demonstrated that the IPTO model recapitulates cellular heterogeneity and molecular features of original tumors. Crucially, we showed that the IPTO model predicts patient-specific drug responses, including resistance mechanisms, in a prospective patient cohort. Collectively, the IPTO model represents a major breakthrough in preclinical modeling of human cancers, which provides a path toward personalized cancer therapy.
536 _ _ |a 311 - Zellbiologie und Tumorbiologie (POF4-311)
|0 G:(DE-HGF)POF4-311
|c POF4-311
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a brain metastasis
|2 Other
650 _ 7 |a glioblastoma
|2 Other
650 _ 7 |a patient tumor organoid
|2 Other
650 _ 7 |a predictive patient model
|2 Other
650 _ 7 |a temozolomide
|2 Other
650 _ 7 |a tumor heterogeneity
|2 Other
700 1 _ |a Ma, Xiujian
|0 P:(DE-He78)88de8ba75b18dd92d742eb7eab04a1b3
|b 1
|e First author
700 1 _ |a Hua, Wei
|b 2
700 1 _ |a Wang, Changwen
|0 P:(DE-He78)be724b82903aa397737196d8200edb30
|b 3
700 1 _ |a Chu, Youjun
|b 4
700 1 _ |a Sun, Meng
|b 5
700 1 _ |a Fermi, Valentina
|b 6
700 1 _ |a Hamelmann, Stefan
|0 P:(DE-He78)875b52cddc351d6eca86de4f404f4631
|b 7
700 1 _ |a Lindner, Katharina
|0 P:(DE-He78)9c599f876c762bc78d289674c15ba4a5
|b 8
700 1 _ |a Shao, Chunxuan
|0 P:(DE-He78)7e77b1ec44a0797f186de678c66f80a0
|b 9
700 1 _ |a Zaman, Julia
|0 P:(DE-He78)786f582fd4178a697bb48213edd8aad4
|b 10
700 1 _ |a Tian, Weili
|0 P:(DE-He78)013c1f7493419ce6a1a10fd28abb172b
|b 11
700 1 _ |a Zhuo, Yue
|0 P:(DE-He78)24e61e2f659895c9e6d595647a29bf36
|b 12
700 1 _ |a Harim, Yassin
|0 P:(DE-He78)044b8e7cc52bce80fe9afd70f8f4d44e
|b 13
700 1 _ |a Stöffler, Nadja
|0 P:(DE-He78)79d514e9270d1a0c8b17992db50542f1
|b 14
700 1 _ |a Hammann, Linda
|0 P:(DE-He78)6268906e54e5ca1f69e966a42d92bff7
|b 15
700 1 _ |a Xiao, Qungen
|0 P:(DE-He78)4ddaf0b8a060cc0da9341ecef9ce161e
|b 16
700 1 _ |a Jin, Xiaoliang
|0 P:(DE-He78)ec03875913cf6c00f279fe768d4d7b5d
|b 17
700 1 _ |a Warta, Rolf
|b 18
700 1 _ |a Lotsch, Catharina
|b 19
700 1 _ |a Zhuang, Xuran
|b 20
700 1 _ |a Feng, Yuan
|b 21
700 1 _ |a Fu, Minjie
|b 22
700 1 _ |a Zhang, Xin
|b 23
700 1 _ |a Zhang, Jinsen
|b 24
700 1 _ |a Xu, Hao
|b 25
700 1 _ |a Qiu, Fufang
|b 26
700 1 _ |a Xie, Liqian
|b 27
700 1 _ |a Zhang, Yi
|b 28
700 1 _ |a Zhu, Wei
|b 29
700 1 _ |a Du, Zunguo
|b 30
700 1 _ |a Salgueiro, Lorena
|0 P:(DE-HGF)0
|b 31
700 1 _ |a Schneider, Mark
|b 32
700 1 _ |a Eichhorn, Florian
|b 33
700 1 _ |a Lefevre, Arthur
|b 34
700 1 _ |a Pusch, Stefan
|0 P:(DE-He78)f2efee17b6ca2f790176a2c036912536
|b 35
700 1 _ |a Grinevich, Valery
|b 36
700 1 _ |a Ratliff, Miriam
|0 P:(DE-He78)ce9cbc0fcc94b04884d88105f812ed01
|b 37
700 1 _ |a Loges, Sonja
|0 P:(DE-He78)1eee9e84c0f8c90a97fe40b6e8252a23
|b 38
700 1 _ |a Bunse, Lukas
|0 P:(DE-He78)e579130c57e8c686ed1c2dedfa595985
|b 39
700 1 _ |a Sahm, Felix
|0 P:(DE-He78)a1f4b408b9155beb2a8f7cba4d04fe88
|b 40
700 1 _ |a Xiang, Yangfei
|b 41
700 1 _ |a Unterberg, Andreas
|b 42
700 1 _ |a von Deimling, Andreas
|0 P:(DE-He78)a8a10626a848d31e70cfd96a133cc144
|b 43
700 1 _ |a Platten, Michael
|0 P:(DE-He78)5ef8651b0f857b9c640aa5b1498c43b5
|b 44
700 1 _ |a Herold-Mende, Christel
|b 45
700 1 _ |a Wu, Yonghe
|b 46
700 1 _ |a Liu, Haikun
|0 P:(DE-He78)76aeb2431f7458c9261e69c5420390c6
|b 47
700 1 _ |a Mao, Ying
|b 48
773 _ _ |a 10.1016/j.stem.2025.01.002
|g p. S1934590925000025
|0 PERI:(DE-600)2375356-0
|n 4
|p 652-669.e11
|t Cell stem cell
|v 32
|y 2025
|x 1934-5909
909 C O |p VDB
|o oai:inrepo02.dkfz.de:298907
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)88de8ba75b18dd92d742eb7eab04a1b3
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)be724b82903aa397737196d8200edb30
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-He78)875b52cddc351d6eca86de4f404f4631
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 8
|6 P:(DE-He78)9c599f876c762bc78d289674c15ba4a5
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 9
|6 P:(DE-He78)7e77b1ec44a0797f186de678c66f80a0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 10
|6 P:(DE-He78)786f582fd4178a697bb48213edd8aad4
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 11
|6 P:(DE-He78)013c1f7493419ce6a1a10fd28abb172b
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 12
|6 P:(DE-He78)24e61e2f659895c9e6d595647a29bf36
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 13
|6 P:(DE-He78)044b8e7cc52bce80fe9afd70f8f4d44e
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 14
|6 P:(DE-He78)79d514e9270d1a0c8b17992db50542f1
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 15
|6 P:(DE-He78)6268906e54e5ca1f69e966a42d92bff7
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 16
|6 P:(DE-He78)4ddaf0b8a060cc0da9341ecef9ce161e
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 17
|6 P:(DE-He78)ec03875913cf6c00f279fe768d4d7b5d
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 31
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 35
|6 P:(DE-He78)f2efee17b6ca2f790176a2c036912536
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 37
|6 P:(DE-He78)ce9cbc0fcc94b04884d88105f812ed01
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 38
|6 P:(DE-He78)1eee9e84c0f8c90a97fe40b6e8252a23
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 39
|6 P:(DE-He78)e579130c57e8c686ed1c2dedfa595985
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 40
|6 P:(DE-He78)a1f4b408b9155beb2a8f7cba4d04fe88
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 43
|6 P:(DE-He78)a8a10626a848d31e70cfd96a133cc144
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 44
|6 P:(DE-He78)5ef8651b0f857b9c640aa5b1498c43b5
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 47
|6 P:(DE-He78)76aeb2431f7458c9261e69c5420390c6
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-311
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Zellbiologie und Tumorbiologie
|x 0
914 1 _ |y 2025
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2024-12-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2024-12-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2024-12-17
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-17
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CELL STEM CELL : 2022
|d 2024-12-17
915 _ _ |a IF >= 20
|0 StatID:(DE-HGF)9920
|2 StatID
|b CELL STEM CELL : 2022
|d 2024-12-17
920 1 _ |0 I:(DE-He78)A240-20160331
|k A240
|l A240 Molekulare Neurogenetik
|x 0
920 1 _ |0 I:(DE-He78)B300-20160331
|k B300
|l KKE Neuropathologie
|x 1
920 1 _ |0 I:(DE-He78)HD01-20160331
|k HD01
|l DKTK HD zentral
|x 2
920 1 _ |0 I:(DE-He78)D170-20160331
|k D170
|l KKE Neuroimmunologie und Hirntumorimmunologie
|x 3
920 1 _ |0 I:(DE-He78)B320-20160331
|k B320
|l KKE Neuroonkologie
|x 4
920 1 _ |0 I:(DE-He78)A420-20160331
|k A420
|l Personalisierte Medizinische Onkologie
|x 5
920 0 _ |0 I:(DE-He78)A240-20160331
|k A240
|l A240 Molekulare Neurogenetik
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)A240-20160331
980 _ _ |a I:(DE-He78)B300-20160331
980 _ _ |a I:(DE-He78)HD01-20160331
980 _ _ |a I:(DE-He78)D170-20160331
980 _ _ |a I:(DE-He78)B320-20160331
980 _ _ |a I:(DE-He78)A420-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21